Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 17/20 | 0.87 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2943130 | 0.95 | MLYCD (0.87) | MLYCD | |
| SCHEMBL5234307 | 0.90 | MLYCD (0.81) | MLYCD | |
| SCHEMBL2941249 | 0.90 | MLYCD (0.81) | MLYCD | |
| SCHEMBL2941950 | 0.90 | MLYCD (0.81) | MLYCD | |
| SCHEMBL2944434 | 0.89 | MLYCD (0.69) | MLYCDNR1H2NR1H3 | |
| SCHEMBL2943278 | 0.89 | MLYCD (0.80) | MLYCD | |
| SCHEMBL2942934 | 0.89 | MLYCD (0.80) | MLYCD | |
| SCHEMBL2944600 | 0.88 | MLYCD (0.78) | MLYCD | |
| SCHEMBL6846355 | 0.87 | MLYCD (0.67) | MLYCDNR1H2NR1H3 | |
| SCHEMBL2942152 | 0.87 | MLYCD (0.77) | MLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040087627-A1 | Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-05-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087627-A1 | Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors | ME2, PC, ACACA | MLYCD 6/4885NR1H2 1139/4885NR1H3 1227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.